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SUMMARY
Sperm DNA Fragmentation has been extensively studied for more than a decade. In the 1940s the uniqueness of the spermatozoa
protein complex which stabilizes the DNA was discovered. In the fifties and sixties, the association between unstable chromatin
structure and subfertility was investigated. In the seventies, the impact of induced DNA damage was investigated. In the 1980s the
concept of sperm DNA fragmentation as related to infertility was introduced as well as the first DNA fragmentation test: the Sperm
Chromatin Structure Assay (SCSA). The terminal deoxynucleotidyl transferase nick end labelling (TUNEL) test followed by others
was introduced in the nineties. The association between DNA fragmentation in spermatozoa and pregnancy loss has been exten-
sively investigated spurring the need for a therapeutic tool for these patients. This gave rise to an increased interest in the aetiology
of DNA damage. The present decade continues within this research area. Some of the more novel methods recently submerging are
sorting of cells with increased DNA fragmentation and hyaluronic acid (HA) binding techniques. The clinical value of these tests
remains to be elucidated. In spite of half a century of research within the area, this analysis is not routinely implemented into the fer-
tility clinics. The underlying causes are multiple. The abundance of methods has impeded the need for a clinical significant thresh-
old. One of the most promising methods was commercialized in 2005 and has been reserved for larger licensed laboratories. Myriads
of reviews and meta-analyses on studies using different assays for analysis of DNA fragmentation, different clinical Artificial Repro-
ductive Treatments (ART), different definitions of successful ART outcome and small patient cohorts have been published. Although
the area of DNA fragmentation in spermatozoa is highly relevant in the fertility clinics, the need for further studies focusing on stan-
dardization of the methods and clinical implementation persists.
INTRODUCTION
Paternal contribution to the fertilization and to the develop-
ment of healthy offspring is of vital importance. There have been
reports of an increased risk of schizophrenia or autism in off-
spring from fathers with increasing age (Sipos et al., 2004;
Reichenberg et al., 2006) and an increased risk of cancer in off-
spring from fathers with increased level of sperm DNA fragmen-
tation because of smoking (Ji et al., 1997). Furthermore, some
spontaneous dominant genetic diseases, epilepsy and some
birth defects are linked to paternal contribution (reviewed in Ait-
ken et al., 2009). In a number of studies, an association between
increased DNA fragmentation in the spermatozoa and subfertil-
ity has been reported. Comparing studies of fertile and infertile
males have shown that the amount of DNA fragmentation is sig-
nificantly higher in the infertile group (Evenson et al., 1999;
Spano et al., 2000; Saleh et al., 2003; Alkhayal et al., 2013;
Oleszczuk et al., 2013). An abnormal chromatin packing is more
recurrent in men with normozoospermia undergoing ART treat-
ment than in fertile men (Alkhayal et al., 2013). If the man has
increased DNA fragmentation in the spermatozoa, a prolonged
Time To Pregnancy (TTP) (Evenson et al., 1999), an increased
risk of a missed abortion (Virro et al., 2004; Lin et al., 2008; Zini
et al., 2008; Kennedy et al., 2011; Dar et al., 2013) and a signifi-
cantly reduced success rate in in vivo fertilization of the partner
have been observed (Spano et al., 2000; Bungum et al., 2004,
2007; Giwercman et al., 2010; Zini, 2011). When seeking fertility
treatment, it seems that sperm DNA fragmentation is of vital
importance when planning the course of treatment. A study
included 131 couples seeking fertility treatment by intrauterine
inseminations (IUI). Twenty-three of the male patients had an
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increased amount of SCSA defined DNA fragmentation followed
by a pregnancy rate of 4% in their partner (Bungum et al., 2004).
A later study including 387 cycles showed that the pregnancy
rate dropped to 3% if the level of DNA fragmentation exceeded
30% (Bungum et al., 2007). In a smaller Danish study including
48 couples, no pregnancies were observed in couples, where the
male DNA fragmentation exceeded 27% (Boe-Hansen et al.,
2006). DNA fragmentation may affect the fertilization rate after
in vitro fertilization (IVF). No clear association between
increased amount of DNA fragmentation and intracytoplasmic
sperm injection (ICSI) has been established. However, DNA frag-
mentation may affect the clinical pregnancy rate (Oleszczuk
et al., 2016) (Bungum et al., 2007; Dar et al., 2013).
It thus seems that an increase in DNA fragmentation primarily
affects in vivo fertility, either by reducing natural conception or
by a significant reduction in successful intrauterine insemina-
tions. It is estimated that up to 20% of males with semen param-
eters otherwise suitable for IUI treatment present with a DFI
˃30%. On this basis, the authors behind this study recommend
that IVF or ICSI being the first choice of treatment if the amount
of DNA fragmentation exceeds 30% (Giwercman et al., 2010;
Bungum et al., 2011). However, in the study from Oleszczuk
et al. (2016) it was found that the fertilization rates might also be
decreased after IVF when DFI by SCSA exceeds 30%. For high
degree of DFI, it thus might be relevant to proceed the treatment
using ICSI (Oleszczuk et al., 2016).
Together, these studies provide important insight into the sig-
nificance of sperm DNA fragmentation when treating couples
for infertility.
With this in mind - why is sperm DNA fragmentation testing
not a standard diagnostic tool in the treatment of the male fertil-
ity patient?
The journey regarding DNA fragmentation in spermatozoa has
been long and began more than half a century ago.
HISTORICAL OVERVIEW
Forties, fifties and sixties
In 1946, Pollister and Mirsky discovered that a large part of the
protein complexes surrounding the DNA in trout sperm was not
composed of histones but of protamines (Pollister & Mirsky,
1946). Later Alfert found that the protamines replace the his-
tones after meiosis in the maturation of the salmon spermatozoa
(Alfert, 1956). Today it is estimated that only 5–15% of the chro-
matin in the human spermatozoa consist of histones and the
major part consists of protamines (Castillo et al., 2015). Along-
side the discovery of the double helix in 1953, Leuchtenberger
et al. (1953) discovered that the amount of DNA from infertile
males had a significantly larger variation compared with fertile
males. Already at this time, it was discovered that the quality of a
sperm sample was more than a question of number and motility
of the spermatozoa (Leuchtenberger et al., 1953).
The seventies
During the seventies, an increasing interest in a possible asso-
ciation between exposure of DNA damaging agents and a possi-
ble reduction in fertility emerged. In 1970, Ringertz et al. used
an assay where bull spermatozoa were heated and the subse-
quent denaturation of the DNA was detected with acridine
orange followed by microfluoriemetry. They realized that the
spermatozoa possessed an increased stability during the
spermiogenesis (Ringertz et al., 1970). A decrease in epididymal
sperm count and weight of the testis was observed in mice after
exposure to irradiation. Subsequently, an increased pre-implan-
tation loss was observed in the female mice (Searle & Beechey,
1974).
The eighties
In the eighties, the technology for molecular biology
advanced. Evenson et al. developed a flow cytometric assay for
detection of DNA fragmentation in spermatozoa (Evenson et al.,
1980). They called the assay Sperm Chromatin Structure Assay
(SCSA). The assay is based on the detection of DNA fragmenta-
tion by flow cytometry. The sperm DNA is denaturized by acid at
sites of DNA strand breaks and subsequent stained with the fluo-
rescent cationic dye Acridine Orange (AO). In this assay, AO
attaches to the DNA in the ratio of approximately two AO mole-
cules per phosphate group (Evenson & Jost, 1994). When the
laser from the flow cytometer illuminates the cells, AO fluoresces
with a green emission when bound to double stranded (db) DNA
and a red emission when bound to singe stranded (ss) DNA. Fur-
thermore, the flow cytometer measures forward scatter and side
scatter of the sample and this can help exclude debris from the
sample. Usually a total of 5000–10,000 cells are analysed. DNA
Fragmentation Index (DFI) is described as the percent wise ratio
of red florescence to green + red fluorescence (Larson et al.,
2000; Evenson et al., 2002; Larson-Cook et al., 2003). SCSA also
measures High DNA Stainability (HDS), which is believed to be
an expression of immature spermatozoa containing excess his-
tones or other abnormal proteins (Evenson et al., 2002; Bungum
et al., 2004).
The nineties
The field of single cell electrophoresis was developed in the
eighties and optimized during the nineties making it possible to
detect DNA fragmentation by the comet assay. The comet assay
was a novel diagnostic tool for DNA fragmentation and was used
to emphasize that spermatozoa from infertile men were more
susceptible to induced damage than spermatozoa from fertile
men. In the comet assay, 200–300 cells are covered with agarose
gel and subsequently lysed. If the DNA is embedded with breaks,
the supercoiling of the DNA is released allowing the DNA to
migrate towards the anode. This migration leaves a comet-like
tail and the fluorescent intensity of the tail relates to the number
of DNA breaks (Hughes et al., 1996; Aravindan et al., 1997).
In the nineties, TUNEL used to detect DNA fragmentation in
human spermatozoa was developed. In this assay a terminal
deoxynucleotidyl transferase labels the DNA strand breaks with
fluorescent dUTP nucleotides. The assay can be performed using
either flow cytometry or microscopy. Thus, both the neutral and
alkaline comet assay and the TUNEL assay are considered ‘di-
rect’ assays as they measure actual DNA strand breaks, whereas
some of the other assays developed measure the DNA suscepti-
bility to denature at sites of ss or ds DNA breaks or a differenti-
ated binding of a dye to ds- or ssDNA (Gorczyca et al., 1993; Zini
& Sigman, 2009; Henkel et al., 2010).
The zeroes
In the zeroes, other methods for determination of DNA frag-
mentation appeared. The DNA Breakage Detection-Florescence
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in situ Hybridization (DBD-FISH) was developed for human
spermatozoa. In this assay, the spermatozoa are fixed in an
agarose matrix and the DNA is transformed into ssDNA by an
alkaline unwinding solution. After the proteins are removed,
the DNA is made accessible to hybridization with relevant
probes that highlight the area for analysis. If the DNA strand
contains increased amount of DNA breaks more probes will
hybridize resulting in an increased fluorescence. This tech-
nique can be used for detecting DNA damage within specific
sequence areas (Fernandez et al., 2000). The Sperm Chromatin
Dispersion (SCD) test was also developed in this decade and
was used to detect spermatozoa with increased amount of
DNA fragmentation. In this assay, the spermatozoa are embed-
ded in an agarose matrix and exposed to a lysing solution.
The relaxed DNA loops prevent dispersion into the surround-
ing area. With specific DNA fluorochromes and a fluorescence
microscope, the dispersed DNA is seen as a halo surrounding
the nuclei. If the DNA is fragmented, little dispersion is
seen resulting in a small halo. This makes it possible to
detects spermatozoa with increased amount of DNA fragmen-
tation (Fernandez et al., 2003). Two years later, an advanced
SCD test was developed as a kit, Halosperm (Fernandez
et al., 2005).
In 2006, Li et al. developed the ɣH2AX assay to determine dou-
ble strand breaks in human spermatozoa. The assay takes advan-
tage of the fact that some protein-kinases induce
phosphorylation of Ser139 on the histone H2AX. Phosphospeci-
fic antibodies are able to recognize the phosphorylated serine
residue. These are subsequent quantified by a flow cytometer.
Although most histones are replaced by protamines in human
spermatozoa during the spermatogenesis, a small fraction
remains in the nucleosome (around 15%). This fraction also con-
tains the H2AX histone. In a recent study in 2015, Garolla et al.
investigated the predictive value of the method. The pregnancy
rate after ICSI was investigated and the method was compared
with TUNEL. In this study, it was seen that the ɣH2AX percent-
age was higher in the males from non-pregnant couples. This
study also showed that the ɣH2AX has a better predictive value
than TUNEL. In the present form, the method seems to be rather
time consuming, as samples need more than 3 h of preparation
before the flow cytometric analysis can be performed. This com-
pared to the strict protocol from SCSA where samples can be
prepared within few minutes (Li et al., 2006; Garolla et al., 2015;
Evenson, 2016).
The tenths
From the late zeroes and into the tenths the focus concerning
DNA fragmentation shifted from development of methods to the
aetiology of sperm DNA fragmentation. Furthermore, it became
more evident that increased DNA fragmentation could be a valu-
able tool when deciding which type of fertility treatment the
couple should be offered. Several studies added to the viewpoint
that fertility treatment with IUI had very low chance of resulting
in pregnancy if the SCSA-DFI in the spermatozoa was increased.
However, the implantation rate after ICSI is not affected by
increased amount of DNA fragmentation in the spermatozoa, it
has been seen that the risk of early pregnancy loss is increased in
these couples (Carrell et al., 2003; Borini et al., 2006; Gil-Villa
et al., 2009; Brahem et al., 2011; Absalan et al., 2012; Oleszczuk
et al., 2016).
In 2005, Greco et al. showed that ICSI with testicular sperm
resulted in a significantly higher clinical pregnancy rate com-
pared with ICSI where ejaculated sperm was used. This provided
one of the first treatment options for male fertility patients with
increased sperm DNA fragmentation. This study also gave
insight to the aetiology of DNA damage as at least a part of the
DNA damage seemed to appear after the spermatozoa have left
the testis (Greco et al., 2005). Recently, both Esteves et al. and
Pabuccu et al. achieved similar results. Other methods such as
intracytoplasmic morphologically selected sperm injection
(IMSI) and motile sperm organelle morphology examination
(MSOME) have been used in order to circumvent the negative
effects of increased DNA fragmentation. These methods are
based on a real time examination of the spermatozoa under an
increased magnification (up to 9 13.000) which makes it possi-
ble to choose spermatozoa with better chromatin status and
lower aneuploidy rate. If the spermatozoa showed a lack of vac-
uoles, the results improved further (Garolla et al., 2008, 2014;
Gosalvez et al., 2013). In a recent study, Bradley et al. compared
fertilization rates after physiological ICSI (PICS), IMSI and
extraction of testicular sperm, respectively. They found that the
use of testicular sperm significantly increased the fertilization
rate, pregnancy rate and live birth rate after ICSI for patients
with increased DNA fragmentation (Bradley et al., 2016).
DNA fragmentation and infertility
A substantial amount of literature that strengthened the theory
of a connection between increased DNA fragmentation and
infertility had been published, and in 2015 Zini concluded that
testing for DNA fragmentation should be a part of the routine
male infertility diagnosing (Esteves et al., 2015; Zini, 2015;
Pabuccu et al., 2016).
As the research in the area expanded, several studies show that
the origin of DNA fragmentation can be very diverse. Link has
been seen between increased DNA fragmentation and inadver-
tent effects during the spermiogenesis, increased amount of
oxidative stress, sperm collection methods, storage temperature,
varicocoele, bacterial infections, age, temperature of the testes
and reaction to medicine (reviewed in Gonzalez-Marin et al.,
2012). It is thus possible that the damage to the DNA happens in
multiple steps. This has probably contributed to the blurred pic-
ture of DNA fragmentation. One theory is that the DNA is sub-
jected to damaging events during the spermatogenesis. This
could include nicks in the backbone of the DNA or poor packag-
ing of the chromatin during the replacement of histones. Subse-
quently, the already weakened DNA is more susceptible to
external stressors such as medication, temperature and Reactive
Oxygen Species (ROS) (McPherson & Longo, 1993; Pradeepa &
Rao, 2007).
Antioxidants
The role of antioxidants has been studied extensively in several
areas in the last decade. Regarding spermatozoa, ROS are
believed to play a part in the presence of DNA fragmentation.
ROS play a positive role in several crucial functions such as pro-
liferation and differentiation of cells. However, a pathogenic
effect can occur when the balance between ROS and antioxi-
dants are disturbed. This can result in an excess of ROS, for
example in the reproductive tract or in the seminal plasm. It has
been shown in several studies that antioxidants can have a
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positive impact on some of the primary seminal parameters
(Zini et al., 2009; Abad et al., 2013; Agarwal et al., 2014). The dis-
tribution of dietary supplements to males with increased DFI
have previously shown a significant reduction in DFI and an
increase in the clinical pregnancy rate (Wright et al., 2014). How-
ever, the overall effect of antioxidants remains controversial.
This is mainly because of non-standardized assays for determi-
nation of ROS or antioxidant capacity, diversity in methods for
determination of DNA fragmentation, lack of distinction
between direct and indirect antioxidants and inadequate data on
fertilization and pregnancy rates (Chen et al., 2013).
Novel methods
In the present decade, the magnetic activated cell sorting
(MACS) technique was enhanced. This method was used for the
first time in connection to fertility treatment in the zeroes
(Paasch et al., 2007). In this assay, magnetic particles conjugated
to proteins or antibodies target the cells of interest. This could
be apoptotic surface markers like externalized phospholipid
phosphatidylserine (PS). PS has a high affinity for annexin V,
which cannot cross the membrane. Any conjugation between
the two will therefore happen on spermatozoa with externalized
PS, which is seen in apoptotic cells. The magnetic particles, and
thereby the apoptotic cells, can subsequently be removed by a
magnetic cell separation column (Said et al., 2008).
A novel method where spermatozoa with increased amount
of DNA fragmentation are separated by fluorescence-activated
cell sorting has recently been presented. The spermatozoa are
stained using a YO-PRO staining technique. The researchers
behind the study showed that it is possible to separate the dead
spermatozoa and the spermatozoa with increased amount of
DNA fragmentation from the normal spermatozoa. This makes
it possible to optimize the sperm sample before fertility treat-
ment like ICSI is initiated (Ribeiro et al., 2013). However, recent
research has shown that methods where ICSI is optimized
remains controversial (Tavalaee et al., 2012; Troya & Zorrilla,
2015). Another novel method being investigated in the present
decade is the possibility of detecting damage in spermatozoa
by oligopeptides. A synthetic oligopeptide binds to the dam-
aged DNA. The non-binding end of the oligopeptide consists of
a rhodamine B dye that can be detected with fluorescence
microscopy. There was seen a correlation of the amount of
DNA damage detected with this method and the more classical
methods such as SCD, comet and TUNEL (Enciso et al., 2012).
Another novel method that has been studied in the present
decade is the HA binding technique. HA surrounds the oocyte
only allowing spermatozoa with sufficient expression of specific
receptors to fertilize it. It seems that there is an inverse associa-
tion between the ability of spermatozoa to bind to HA and
chromosomal abnormalities in the spermatozoa (Mokanszki
et al., 2012). In a study, it was found that HA binding test
increased the chance of selecting a spermatozoon with a low
amount of DNA fragmentation possibly optimizing the chance
of pregnancy. A commercial kit has been developed thereby
increasing the availability to the method (Parmegiani et al.,
2010) (Parmegiani et al., 2012). However, in a recent meta-
analysis it was not found that HA binding test increases fertil-
ization rates after ICSI (Beck-Fruchter et al., 2016) and further
research in the area is thus needed for this test to have a rele-
vance in the fertility clinics.
DNA fragmentation and pregnancy loss
Research continuously seems to focus on the possible associa-
tion between sperm DNA fragmentation and recurrent preg-
nancy loss (Coughlan et al., 2015; Leach et al., 2015; Bareh et al.,
2016; Zidi-Jrah et al., 2016). Furthermore, an increasing interest
has supervened regarding the types of fragmentations present in
the DNA (Wei et al., 2015) and how DNA fragmentation can be
reduced in cryopreservation (Ghorbani et al., 2016; Kably-Ambe
et al., 2016; Simonenko et al., 2016). Recent papers have shown
a possible correlation between an increased amount of DNA
fragmentation and some of the natural antioxidants present in
the seminal plasma like superoxide dismutase (Wdowiak et al.,
2015) and glutathione peroxidase (Dorostghoal et al., 2017).
In spite of the effort in the last couples of decades, there is still
a long way to go within the field of DNA fragmentation in sper-
matozoa. Substantial amounts of reviews and meta-analysis
have been published, many of them imploring further studies
with a controlled, randomized study population and more sensi-
tive assays (Lewis et al., 2013; Palermo et al., 2014; Zhao et al.,
2014; Osman et al., 2015).
In Fig. 1, an illustrative view of the historical development of
DNA fragmentation in spermatozoa is presented.
DISCUSSION AND CONCLUSION
In spite of half a century0s research and the widely accepted
conviction that infertility and sperm DNA fragmentation are
linked, this diagnostic tool is not yet a standard care in the fertil-
ity clinics.
Several issues contribute to this. The lack of uniformity in all
assays, (except the SCSA) for analysis of DNA fragmentation and
the absence of a clear clinical threshold, a myriad of studies
using different assay, different clinical ART and diverse out-
comes and small patient cohorts are all contributing factors.
One of the obstacles is the difference in the methods used to
assess the amount of DNA fragmentation present in the sperma-
tozoa. Reviews and meta-analysis compare outcomes of fertility
treatment across methods, which impede the progress of imple-
menting the analysis in the fertility clinics. Another obstacle is
the lack in knowledge concerning the aetiology of DNA fragmen-
tation. There are several theories of the aetiology of DNA frag-
mentation. One is a two-step model for the development of DNA
fragmentation in spermatozoa. In step one, an error in the sper-
matogenesis weakens the DNA and impairs the chromatin
remodelling. This results in spermatozoa with low levels of
nuclear protamine. In the second step, the vulnerable DNA is
more susceptible to oxidative stress (Christensen & Birck, 2015).
Another theory is that DNA fragmentation occurs after an inter-
rupted apoptosis. An increased activity of apoptosis related pro-
teins such as caspase 3 and 7, Fas and cPARP has been seen in
samples with abnormal semen parameter or increased amount
of DNA fragmentation. Apoptosis is believed to be activated by
testicular conditions and oxidative stress. It is speculated that
apoptosis could be the main pathway to DNA fragmentation in
spermatozoa (Sakkas et al., 2004; Manente et al., 2015; Muratori
et al., 2015). An association between chromatin immaturity and
DNA fragmentation has also been seen; which can be suggested
as an accelerator for DNA fragmentation. Chromatin immaturity
is believed to be caused by defects in the spermatogenesis (Sati
et al., 2008). The aetiology of DNA fragmentation is far from
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illuminated and the different theories are not mutually exclusive.
It is possible that chromatin immaturity or oxidative stress trig-
gers the activation of the apoptotic pathway. Furthermore, it is
known that exogenous exposures, such as environment, lifestyle
and health also contribute to increased amount of DNA
fragmentation.
When relating to DNA fragmentation and infertility, the salient
point is implementation in the fertility clinic. It is essential that
this analysis is practicable in the daily work. Furthermore, uni-
formity and reproducibility across laboratories are of crucial
importance. As the association between DNA fragmentation and
pregnancy outcome is well established the analysis can be fully
implemented as a diagnostic tool in the fertility clinics however,
the aetiology of DNA fragmentation has not yet been fully
elucidated.
When comparing outcomes of the different methods, there is
a moderate correlation between SCSA, TUNEL and SCD with
regard to levels of sperm DNA fragmentation. However, the Acri-
dine Orange staining Technique (AOT) does not seem to have a
clinical significance for fertility testing. In the AOT assay, the
amount of DNA fragmentation is determined after a coloration
with acridine orange and a microscopic evaluation. The method
has recently been discredited by Evenson as a result of AO stain-
ing fluorescence fading and artefacts induced by glass/AO inter-
actions (Evenson, 2016). Nonetheless SCSA also uses AO for the
colouration of the DNA, the evaluation by microscopy vs. flow
cytometer seems to be of crucial importance. Additionally, a
study has shown that the neutral comet assay fails to distinguish
between fertile donors and infertility patients. It does, however,
relate to the risk of miscarriage. The alkaline comet assay seems
to have a moderate correlation with SCSA, TUNEL and SCD.
When the predictive values of the methods are assessed, there
seems to be conflicting results regarding predictability for fertil-
ization. It has been reported by Ribas-Maynou in 2013 that the
alkaline comet assay has the highest sensitivity followed by the
TUNEL, SCD and SCSA analysis and subsequently the neutral
comet assay. Chohan et al. found a strong relationship between
SCSA and TUNEL (Chohan et al., 2006; Ribas-Maynou et al.,
2013). Furthermore, a systemic review and meta -analysis from
2016 claims that the comet assay and the TUNEL assay has the
best predictability after IVF or ICSI of the methods assessed
(Cissen et al., 2016).
Other tests, like SCD are available as an easy to use kit but
might be less accurate. However, the comet assay has shown the
best predictability in some studies, it lacks a clear threshold and
the methodology can change among laboratories. Furthermore,
the comet assay as well as the SCD test, suffers by the fact
that the evaluation of DNA fragmentation is estimated in only
200–300 cells. In addition, the comet assay is labour-intensive.
The agreement between TUNEL and SCSA has been seen several
times (Chohan et al., 2006; Ribas-Maynou et al., 2013; Evenson,
2016). When comparing the two flow cytometric assays, the
TUNEL assay requires extensive preparation of the spermatozoa
before analysis can be performed and there is currently a lack of
a strict protocol. This inhibits the implementation of this
method as a diagnostic tool in a clinical setting. SCSA has a strict
protocol developed in 1980 and has been used for fertility assess-
ment in both animal and human spermatozoa. The protocol is
relatively easy and the analysis is not time consuming. It is pos-
sible to analyse up to 50 samples per day for an experienced lab
technician. The analysis by flow cytometer allows evaluation of
10.000 spermatozoa within a minute or two resulting in a more
robust analysis (Evenson et al., 2002; Evenson & Wixon, 2006;
Zini et al., 2009; Evenson, 2013).
In 2005, the SCSA test was commercialized. Two European
laboratories received license to perform the SCSA test. Fertility
clinics were to ship sperm samples to these larger diagnostic
centres in order to obtain a SCSA-DFI value (Evenson, 2011).
As it is encouraged that DFI is determined using the commer-
cial SCSAsoft software the SCSA analysis have primarily been
restricted to the larger licensed diagnostic laboratories (Even-
son, 2011). In order for the analysis to be implemented into
the individual fertility clinics, an investment in a flow cytome-
ter is required. This has previously been an insurmountable
cost. Recently, smaller bench-top flow cytometers having only
a red and green fluorescent channel and a small air-cooled
Figure 1 Timeline. An illustrative view of the
landmarks and development.
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blue laser has been developed. These are cheaper and require
less space than the larger multichannel flow cytometers, mak-
ing them more suitable for the smaller fertility clinics. More
flexibility concerning software as well as a relocation from the
larger commercial diagnostic labs to the individual fertility
clinic will decrease the costs concerning the analysis thereby
aiding the implementation of the analysis in the fertility
clinics.
Bungum et al. (2011) estimates that 40% of all cases of unex-
plained infertility can be related to increased amount of DNA
damage and suggests a treatment course where patients with
DFI ≥30% measured by SCSA should be referred directly to
IVF/ICSI treatment. Furthermore, it is speculated that even a
moderate increase in DFI (between 20–30% by SCSA) can give
rise to a prolonged TTP – information that the treating physi-
cian can employ when counselling fertility patients and plan-
ning the course of treatment (Bungum et al., 2011). As
mentioned in the introduction, DNA fragmentation also seems
to have implications for the offspring as it is linked to an
increased risk of miscarriage or a number of pathogenic condi-
tions in the offspring (reviewed in Aitken et al., 2009; Sills &
Christensen, 2015). In order for progress within this field a nec-
essary next step is a combination of further clarification of the
aetiology of DNA fragmentation and simplifying and standard-
izing the analysis. While it is very important to standardize all
sperm fragmentation assays for utility in the ART clinic, a bet-
ter understanding on the aetiology of sperm DNA fragmenta-
tion will be needed in order to develop effective therapeutic
strategies for these patients. For couples where the male suffers
from increased amount of DNA fragmentation, ICSI or TESA
are currently the only methods that have shown any positive
effect on the pregnancy rates. Both procedures are invasive
and cannot cope with the increased amount of early pregnancy
loss also seen in this group of patients. The goal must be to
ease the diagnosis of these patients and to clarify the origin of
the DNA fragmentation. This will make it possible to plan a
treatment course with the aim of reducing the amount of DNA
fragmentation and increase the rate of continuous pregnancy
for these couples.
The predictive value of the analysis of DNA fragmentation in
spermatozoa is often criticized. One point of criticism is that the
method cannot predict all failure to conceive. As infertility is the
couple’s problem, one has to consider the fertility of the female
as well. One single test of gamete dysfunction from just one part-
ner of the couple cannot predict the outcome of the fertility
treatment. Determination of DNA fragmentation is not a
replacement of current diagnostic tools for infertility diagnosing.
However, it is a valuable supplement adding independent infor-
mation about the gamete status of the male partner and it is due
time that this analysis becomes a standard tool in the fertility
clinics.
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